Skip to main content Accessibility help
  • Print publication year: 2020
  • Online publication date: September 2020

Chapter 4 - Diagnostic Hysteroscopy: Accuracy and Interpretation of Findings


Hysteroscopy can be used to diagnose endometrial and structural cavity pathologies associated with abnormal uterine bleeding (AUB) and reproductive failure. Optimal interpretation of hysteroscopic findings requires an understanding of the limitations of the technology and incorporation of information obtained from the preceding clinical history and examination. Ideally, hysteroscopy should be avoided during the menstrual period, as the obtained views are likely to be compromised. Although normal endometrial appearances during the secretory phase could potentially be misinterpreted (e.g. as polyps or hyperplastic endometrium), with experience the likelihood of this is small, and so timing the procedure to coincide with the proliferative phase of the menstrual cycle is not necessary or indeed practical

Related content

Powered by UNSILO
1.Clark, TJ, Gupta, JK. Handbook of Outpatient Hysteroscopy: A Complete Guide to Diagnosis and Therapy. London: Hodder Arnold; 2005.
2.Carneiro, M. What is the role of hysteroscopic surgery in the management of female infertility? A review of the literature. Surg Res Pract 2014; 2014: 105412.
3.Moawad, NS, Santamaria, E, Johnson, M, et al. Cost-effectiveness of office hysteroscopy for abnormal uterine bleeding. JSLS 2014; 18(3): e2014.00393.
4.Farquhar, C, Ekeroma, A, Furness, S, et al. A systematic review of transvaginal ultrasonography, sonohysterography and hysteroscopy for the investigation of abnormal uterine bleeding in premenopausal women. Acta Obstet Gynecol Scand 2003; 82(6): 493504.
5.Van Dongen, H, de Kroon, CD, Jacobi, CE, et al. Diagnostic hysteroscopy in abnormal uterine bleeding: a systematic review and meta-analysis. BJOG 2007; 114: 664–75.
6.Clark, J, Voit, D, Gupta, J, et al. Accuracy of hysteroscopy in the diagnosis of endometrial cancer and hyperplasia. JAMA 2002; 288: 1610.
7.Grimbizis, GF, Tsolakidis, D, Mikos, T, et al. A prospective comparison of transvaginal ultrasound, saline infusion sonohysterography, and diagnostic hysteroscopy in the evaluation of endometrial pathology. Fertil Steril 2010; 94: 2720–5.
8.Munro, MG, Critchley, HO, Broder, MS, et al. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynaecol Obstet 2011; 113: 313.
9.Nathani, F, Clark, TJ. Uterine polypectomy in the management of abnormal uterine bleeding: a systematic review. J Minim Invasive Gynecol 2006; 13: 260–8.
10.Cooper, NAM, Clark, TJ, Middleton, L, et al. Outpatient versus inpatient uterine polyp treatment for abnormal uterine bleeding: randomised controlled non-inferiority study. BMJ 2015; 350: h1398.
11.Van Hanegem, N, Breijer, MC, Slockers, SA, et al. Diagnostic workup for postmenopausal bleeding: a randomised controlled trial. BJOG 2017; 124: 231–40.
12.Gkrozou, F, Dimakopoulos, G, Vrekoussis, T, et al. Hysteroscopy in women with abnormal uterine bleeding: a meta-analysis on four major endometrial pathologies. Arch Gynecol Obstet 2015; 291: 1347–54.
13.Mahmud, A, Smith, P, Clark, TJ. The role of hysteroscopy in diagnosis of menstrual disorders. Best Pract Res Clin Obstet Gynaecol 2015; 29: 898907.
14.Golan, A, Cohen-Sahar, B, Keidar, R, et al. Endometrial polyps: symptomatology, menopausal status and malignancy. Gynecol Obstet Invest 2010; 70: 107–12.
15.Costa-Paiva, L, Godoy, C, Antunes, A, et al. Risk of malignancy in endometrial polyps in premenopausal and postmenopausal women according to clinicopathologic characteristics. Menopause 2011; 18: 1278–82.
16.Rackow, B, Jorgensen, E, Taylor, H. Endometrial polyps affect uterine receptivity. Fertil Steril 2011; 95: 2690–2.
17.Bosteels, J, Kasius, J, Weyers, S, et al. Hysteroscopy for treating subfertility associated with suspected major uterine cavity abnormalities. Cochrane Database Syst Rev 2018; (12): CD009461.
18.Munro, M, Critchley, H, Fraser, I. The FIGO classification of causes of abnormal uterine bleeding in the reproductive years. Fertil Steril 2011; 95: 2204–8.e3.
19.Lasmar, R, Barrozo, P, Dias, R, de Oliveira, M. Submucous myomas: a new presurgical classification to evaluate the viability of hysteroscopic surgical treatment. Preliminary report. J Minim Invasive Gynecol 2015; 12: 308–11.
20.Hanstede, M, van der Meij, E, Goedemans, L, Emanuel, M. Results of centralized Asherman surgery, 2003–2013. Fertil Steril 2015; 104: 1561–8.e1.
21.Bougie, O, Lortie, K, Chen, I, Shenassa, H, Singh, S. Treatment of Asherman’s syndrome in an outpatient hysteroscopy setting. J Minim Invasive Gynecol 2015; 22: S122.
22.Demirol, A, Gurgan, T. Effect of treatment of intrauterine pathologies with office hysteroscopy in patients with recurrent IVF failure. Reprod Biomed Online 2004; 8: 590–4.
23.Venetis, C, Papadopoulos, S, Campo, R, et al. Clinical implications of congenital uterine anomalies: a meta-analysis of comparative studies. Reprod Biomed Online 2014; 29: 665–83.
24.Grimbizis, G, Gordts, S, Di Spiezio Sardo, A, et al. The ESHRE/ESGE consensus on the classification of female genital tract congenital anomalies. Hum Reprod 2013; 28: 2032–44.
25.Moawad, NS, Santamaria, E. Hysteroscopy in complex Müllerian anomalies. In Tinelli, A, Pacheo, LA, Haimovich, S, eds., Hysteroscopy. Switzerland: Springer; 2018.
26.Chandler, T, Machan, L, Cooperberg, P, Harris, A, Chang, S. Müllerian duct anomalies: from diagnosis to intervention. Br J Radiol 2009; 82: 1034–42.
27.Bakas, P, Gregoriou, O, Hassiakos, D, et al. Hysteroscopic resection of uterine septum and reproductive outcome in women with unexplained infertility. Gynecol Obstet Invest 2012; 73: 321–5.
28.Rikken, J, Kowalik, C, Emanuel, M, et al. Septum resection for women of reproductive age with a septate uterus. Cochrane Database Syst Rev 2017; (1): CD008576.
29.Di Spiezio Sardo, A, Florio, P, Nazzaro, G, et al. Hysteroscopy outpatient metroplasty to expand dysmorphic uteri (HOME-DU technique): a pilot study. Reproductive BioMedicine Online 2015; 30: 166–74.
30.Nezhat, C, Falik, R, Li, A. Surgical management of niche, isthmocele, uteroperitoneal fistula, or cesarean scar defect: a critical rebirth in the medical literature. Fertil Steril 2017; 107: 6971.
31.Jayaram, PM, Okunoye, GO, Konje, J. Caesarean scar ectopic pregnancy: diagnostic challenges and management options. Obstet Gynaecol 2017; 19: 1320.
32.Kar, S. Hysteroscopy in the diagnosis & management of persistent retained products of conception (RPOC). J Minim Invasive Gynecol 2015; 22: S122–3.
33.Di Spiezio Sardo, A, Calagna, G, Santangelo, F, et al. The role of hysteroscopy in the diagnosis and treatment of adenomyosis. Biomed Res Int 2017; 29(7): 17.
34.Garuti, G, Sambruni, I, Colonnelli, M, Luerti, M. Accuracy of hysteroscopy in predicting histopathology of endometrium in 1500 women. J Am Assoc Gynecol Laparosc 2001; 8(2): 207–13.
35.Polin, S. The effect of tamoxifen on the genital tract. Cancer Imaging 2008; 8: 135–45.
36.Cicinelli, E, Resta, L, Nicoletti, R, et al. Detection of chronic endometritis at fluid hysteroscopy. J Minim Invasive Gynecol 2005; 12: 514–18.
37.Kumar, A, Kumar, A. Hysteroscopic markers in chronic endometritis. J Minim Invasive Gynecol 2017; 24: 1069–70.
38.Royal College of Obstetricians and Gynaecologists. Management of Endometrial Hyperplasia. Green-top Guideline No. 67. London: RCOG; 2016. (accessed November 2019).
39.Mutter, G. Endometrial intraepithelial neoplasia (EIN): will it bring order to chaos? Gynecol Oncol 2000; 76: 287–90.
40.Baak, J. EIN and WHO94. J Clin Path 2005; 58: 16.
41.Owings, R, Quick, C. Endometrial intraepithelial neoplasia. Arch Pathol Lab Med 2014; 138: 484–91.
42.Salman, M, Usubutun, A, Boynukalin, K, Yuce, K. Comparison of WHO and endometrial intraepithelial neoplasia classifications in predicting the presence of coexistent malignancy in endometrial hyperplasia. J Gynecol Oncol 2010; 21: 97.
43.Gupta, J, Chien, P, Voit, D, et al. Ultrasonographic endometrial thickness for diagnosing endometrial pathology in women with postmenopausal bleeding: a meta-analysis. Acta Obstet Gynecol Scand 2002; 81(9): 799816.
44.Smith-Bindman, R, Kerlikowske, K, Feldstein, V, et al. Endovaginal ultrasound to exclude endometrial cancer and other endometrial abnormalities. JAMA 1998; 280: 1510–17.
45.Kadirogullari, P. Prevalence of co-existing endometrial carcinoma in patients with preoperative diagnosis of endometrial hyperplasia. J Clin Diagn Res 2015; 9: QC10–4.
46.Kurman, R, Kaminski, P, Norris, H. The behavior of endometrial hyperplasia: a long-term study of ‘untreated’ hyperplasia in 170 patients. Cancer 1985; 56: 403–12.
47.Terakawa, N, Kigawa, J, Taketani, Y, et al. The behavior of endometrial hyperplasia: a prospective study. J Obstet Gynaecol Res 1997; 23: 223–30.
48.Reed, S, Newton, K, Garcia, R, et al. Complex hyperplasia with and without atypia. Obstet Gynecol 2010; 116: 365–73.
49.Widra, E, Dunton, C, McHugh, M, et al. Endometrial hyperplasia and the risk of carcinoma. Int J Gynecol Cancer 1995; 5: 233–5.
50.Pereira, MC, Vaz, MM, Miranda, SP, et al. Uterine cavity calcifications: a report of 7 cases and a Systematic literature review. J Minim Invasive Gynecol 2014; 21: 346–52.